|
Dr. Tregay is a Managing Director of the newly launched $200 million Novartis Option Fund. Prior to joining the venture group, he was the Executive Director and Head of Strategic Alliances oncology, ophthalmology, and technologies at the Novartis Institutes for BioMedical Research. Prior to joining Novartis, Dr. Tregay held various roles in both business development and research. He holds doctorate and master’s degrees in organic chemistry from Harvard University and a bachelor’s from Davidson College, in North Carolina. | 